Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy

被引：2

作者：

Arrieta, O. G. ^{[1
]}

Ruiz-Patino, A. ^{[2
]}

Cardona, A. F. ^{[3
]}

Martin, C. ^{[4
]}

Raez, L. ^{[5
]}

Zatarain Barron, Z. L. ^{[6
]}

Barron, F. ^{[6
]}

Ricaurte, L. ^{[2
]}

Bravo-Garzon, M. A. ^{[7
]}

Mas, L. ^{[8
]}

Corrales, L. ^{[9
]}

Rojas, L. L. ^{[10
]}

Lupinacci, L. ^{[11
]}

Perazzo, F. ^{[12
]}

Bas, C. ^{[13
]}

Carranza, O. ^{[14
]}

Puparelli, C. ^{[15
]}

Rizzo, M. ^{[16
]}

Ruiz, R. ^{[8
]}

Rolfo, C. ^{[17
]}

Archila, P. ^{[18
]}

Rodriguez, J. ^{[2
]}

Sotelo, C. ^{[2
]}

Vargas, C. ^{[19
]}

Carranza, H. ^{[2
]}

Otero, J. ^{[2
]}

Pino, L. ^{[20
]}

Ortiz, C. ^{[3
]}

Laguado, P. ^{[3
]}

Rosell, R. ^{[21
]}

机构：

[1] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico

[2] Ficmac, Bogota, Colombia

[3] Clin Country, Bogota, Colombia

[4] Inst Alexander Fleming, Dept Onocl, Buenos Aires, DF, Argentina

[5] Florida Int Univ, Hematol Oncol, Mem Canc Inst, Pembroke Pines, FL USA

[6] Inst Nacl Cancerol, Mexico City, DF, Mexico

[7] Hosp Mil Cent, Dept Hematol & Oncol, Bogota, Colombia

[8] Natl Canc Inst Peru, Lima, Peru

[9] Hosp San Juan Dios, San Jose, Costa Rica

[10] Clin Colsanitas, Oncol Dept, Bogota, Colombia

[11] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[12] Cemic Buenos Aires, Buenos Aires, DF, Argentina

[13] Hosp Aleman, Buenos Aires, DF, Argentina

[14] Hosp Privado Comunidad Mar Del Plata, Mar Del Plata, Buenos Aires, Argentina

[15] Inst Alexander Fleming, Dept Oncol, Buenos Aires, DF, Argentina

[16] Htal Austral, Derqui, Argentina

[17] Univ Maryland, College Pk, MD 20742 USA

[18] Ficmac, Med Oncol, Bogota, Colombia

[19] Univ El Bosque, Mol Oncol & Biol Syst Res Grp Fox G, Bogota, Colombia

[20] Fdn Santafe, Canc Inst, Bogota, Colombia

[21] Catalan Inst Oncol Ico Badalona, Germans Trias & Pujol Sci Inst, Canc Biol & Precis Med Program, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

Immunotherapy; hyperprogression; Latin America;

D O I：

10.1016/j.jtho.2019.08.984

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.04-81

引用

页码：S474 / S474

页数：1

共 50 条

[1] Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy
Arrieta, O.
Ruiz-Patino, A.
Cardona, A. F.
Martin, C.
Raez, L.
Zatarain Barron, L.
Barron, F.
Ricaurte, L.
Bravo-Garzon, M. A.
Mas, L.
Corrales-Rodriguez, L.
Rojas, L.
Lupinacci, L.
Perazzo, F.
Bas, C.
Carranza, O.
Pupareli, C.
Rizzo, M.
Ruiz Mendoza, R.
Rolfo, C. D.
Archila, P.
Rodriguez, J.
Sotelo, C.
Vargas, C.
Carranza, H.
Otero, J.
Pino, L. E.
Ortiz, C.
Laguado, P.
Rosell, R.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1194 - S1195
[2] Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy
Kim, Y.
Kim, C. H.
Lee, S.
Lee, H. Y.
Kim, H. S.
Kim, K.
Sun, J.
Ahn, J. S.
Ahn, M.
Park, K.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
[3] Hyperprogression after immunotherapy: Clinical implication and genomic alterations in advanced non-small cell lung cancer patients (NSCLC).
Kim, Youjin
Kim, Chu Hyun
Kim, Hong Sook
Sun, Jong-Mu
Ahn, Jin Seok
Ahn, Myung-Ju
Lee, Se-Hoon
Lee, Ho Yun
Park, Keunchil
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] Efficacy of immunotherapy in Chinese patients with KRASmutant advanced NSCLC
Wang, Z.
Han, X.
Peng, L.
Guo, J.
Kong, L.
Huang, Y.
Tang, N.
Zhang, J.
Wang, M.
He, X.
Li, Z.
Peng, Y.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1067 - S1067
[5] Outcomes for patients with advanced stage NSCLC who completed immunotherapy and outcomes for those who subsequently progressed during follow-up: real world experience
Mason, Holly
Jain, Pooja
Lee, Dan
Franks, Kevin
Clarke, Katy
Teo, Mark
Sun, Fei
Young, Alison
[J]. LUNG CANCER, 2023, 178 : S30 - S31
[6] Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)
Cardona, A. F.
Ruiz-Patino, A.
Arrieta, O. G.
Martin, C.
Raez, L.
Zatarain Barron, Z. L.
Barron, F.
Ricaurte, L.
Bravo-Garzon, M. A.
Mas, L.
Corrales, L.
Rojas, L. L.
Lupinacci, L.
Perazzo, F.
Bas, C.
Carranza, O.
Puparelli, C.
Rizzo, M.
Ruiz, R.
Rolfo, C.
Archila, P.
Rodriguez, J.
Sotelo, C.
Vargas, C.
Carranza, H.
Otero, J.
Pino, L.
Ortiz, C.
Laguado, P.
Rosell, R.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S984 - S985
[7] Outcomes for patients with NSCLC on immunotherapy treatment (squamous)
Khan, M.
Weston, C.
Charalambous, M.
Khan, S.
Ahmed, S.
[J]. LUNG CANCER, 2019, 127 : S46 - S46
[8] Outcomes for patients with NSCLC on immunotherapy treatment (adenocarcinoma)
Khalid, F.
Weston, C.
Enver, M.
Khan, S.
Ahmed, S.
[J]. LUNG CANCER, 2019, 127 : S47 - S47
[9] The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
Manegold, Christian
Dingemans, Anne-Marie C.
Gray, Jhanelle E.
Nakagawa, Kazuhiko
Nicolson, Marianne
Peters, Solange
Reck, Martin
Wu, Yi-Long
Brustugun, Odd Terje
Crino, Lucio
Felip, Enriqueta
Fennell, Dean
Garrido, Pilar
Huber, Rudolf M.
Marabelle, Aurelien
Moniuszko, Marcin
Mornex, Francoise
Novello, Silvia
Papotti, Mauro
Perol, Maurice
Smit, Egbert F.
Syrigos, Kostas
van Meerbeeck, Jan P.
van Zandwijk, Nico
Yang, James Chih-Hsin
Zhou, Caicun
Vokes, Everett
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 194 - 207
[10] The efficacy of chemotherapy in the advanced NSCLC patients who failed with the treatment of EGFR-TKI
Zhou, S.
Ren, S.
Zhang, L.
Sun, H.
Zhou, C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 5 →